Search research articles
Contact Us
Filters
Showing results (61-70 of 251) with videos related to
Page
of 26
Sort By:
Autoimmunity Reviews
|
November 9, 2018
Autoimmune diseases in myelodysplastic syndrome favors patients survival: A case control study and literature review
Julie Seguier, Véronique Gelsi-Boyer, Mikael Ebbo, et al.
Oncotarget
|
June 17, 2014
Therapeutic targeting of c-Myc in T-cell acute lymphoblastic leukemia, T-ALL
Marie Loosveld, Rémy Castellano, Stéphanie Gon, et al.
Cells
|
July 14, 2023
Prognostic Immune Effector Signature in Adult Acute Lymphoblastic Leukemia Patients Is Dominated by γδ T Cells
Anne-Charlotte Le Floch, Marie-Sarah Rouvière, Nassim Salem, et al.
Cancer
|
September 24, 2005
Reduced intensity conditioning prior to allogeneic stem cell transplantation for patients with acute myeloblastic leukemia as a first-line treatment
Didier P Blaise, Jean Michel Boiron, Catherine Faucher, et al.
Leukemia & Lymphoma
|
January 12, 2018
Safety profile of lenalidomide in patients with lower-risk myelodysplastic syndromes without del(5q): results of a phase 3 trial
Antonio Almeida, Pierre Fenaux, Guillermo Garcia-Manero, et al.
Blood
|
September 25, 2012
A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission
Norbert Vey, Jean-Henri Bourhis, Nicolas Boissel, et al.
Plos One
|
April 22, 2021
Prognostic impact of early adjunctive corticosteroid therapy in non-HIV oncology or haematology patients with Pneumocystis jirovecii pneumonia: A propensity score analysis
Mehdi Assal, Jérôme Lambert, Laurent Chow-Chine, et al.
Leukemia & Lymphoma
|
October 23, 2012
Outcome of relapse after allogeneic stem cell transplant in patients with acute myeloid leukemia
Raynier Devillier, Roberto Crocchiolo, Anne Etienne, et al.
Journal of Critical Care
|
September 21, 2021
Herpesviridae in critically ill hematology patients: HHV-6 is associated with worse clinical outcome
Frédéric Gonzalez, Samuel Beschmout, Laurent Chow-Chine, et al.
BMC Cancer
|
August 4, 2010
Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias
Julien Rocquain, Nadine Carbuccia, Virginie Trouplin, et al.
Page
of 26
Search research articles
Search
Showing results (61-70 of 251) with videos related to
Sort By:
Page
of 26
Autoimmunity Reviews
|
November 9, 2018
Autoimmune diseases in myelodysplastic syndrome favors patients survival: A case control study and literature review
Julie Seguier, Véronique Gelsi-Boyer, Mikael Ebbo, et al.
Oncotarget
|
June 17, 2014
Therapeutic targeting of c-Myc in T-cell acute lymphoblastic leukemia, T-ALL
Marie Loosveld, Rémy Castellano, Stéphanie Gon, et al.
Cells
|
July 14, 2023
Prognostic Immune Effector Signature in Adult Acute Lymphoblastic Leukemia Patients Is Dominated by γδ T Cells
Anne-Charlotte Le Floch, Marie-Sarah Rouvière, Nassim Salem, et al.
Cancer
|
September 24, 2005
Reduced intensity conditioning prior to allogeneic stem cell transplantation for patients with acute myeloblastic leukemia as a first-line treatment
Didier P Blaise, Jean Michel Boiron, Catherine Faucher, et al.
Leukemia & Lymphoma
|
January 12, 2018
Safety profile of lenalidomide in patients with lower-risk myelodysplastic syndromes without del(5q): results of a phase 3 trial
Antonio Almeida, Pierre Fenaux, Guillermo Garcia-Manero, et al.
Blood
|
September 25, 2012
A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission
Norbert Vey, Jean-Henri Bourhis, Nicolas Boissel, et al.
Plos One
|
April 22, 2021
Prognostic impact of early adjunctive corticosteroid therapy in non-HIV oncology or haematology patients with Pneumocystis jirovecii pneumonia: A propensity score analysis
Mehdi Assal, Jérôme Lambert, Laurent Chow-Chine, et al.
Leukemia & Lymphoma
|
October 23, 2012
Outcome of relapse after allogeneic stem cell transplant in patients with acute myeloid leukemia
Raynier Devillier, Roberto Crocchiolo, Anne Etienne, et al.
Journal of Critical Care
|
September 21, 2021
Herpesviridae in critically ill hematology patients: HHV-6 is associated with worse clinical outcome
Frédéric Gonzalez, Samuel Beschmout, Laurent Chow-Chine, et al.
BMC Cancer
|
August 4, 2010
Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias
Julien Rocquain, Nadine Carbuccia, Virginie Trouplin, et al.
Page
of 26